Biostar Pharmaceuticals, Inc.
BSPM · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Market Cap | $6,730 | $6,209 | $16,961 | $23,822 |
| - Cash | $173 | $39 | $1,685 | $80 |
| + Debt | $2,326 | $2,773 | $3,095 | $0 |
| Enterprise Value | $8,883 | $8,944 | $18,371 | $23,741 |
| Revenue | $2,384 | $27,130 | $61,417 | $52,729 |
| % Growth | -91.2% | -55.8% | 16.5% | – |
| Gross Profit | $915 | $11,104 | $30,276 | $25,683 |
| % Margin | 38.4% | 40.9% | 49.3% | 48.7% |
| EBITDA | -$1,697 | -$21,189 | $4,775 | $5,810 |
| % Margin | -71.2% | -78.1% | 7.8% | 11% |
| Net Income | -$5,698 | -$25,113 | $4,848 | $809 |
| % Margin | -239% | -92.6% | 7.9% | 1.5% |
| EPS Diluted | -2.5 | -11.36 | 2.3 | 0.49 |
| % Growth | 78% | -593.9% | 369.4% | – |
| Operating Cash Flow | $4,913 | $5,877 | $3,311 | $8,909 |
| Capital Expenditures | $0 | -$59 | -$2,869 | -$982 |
| Free Cash Flow | $4,913 | $5,818 | $441 | $7,927 |